Filed May 20, 2025

Serial No. 79429112

Registered Dec. 23, 2025

Registration No. 8,073,026

Class Pharmaceutical preparations for human use for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; veterinary preparations for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; vaccines for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; therapeutic medicines for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases; therapeutic antibodies for the treatment and prevention of cardiovascular disease, cerebrovascular disease, dyslipidemia, thrombosis, hyperphosphatemia, hypertension, diabetes, cancer, oncological disease, leukemia, metastasis, immunological disorder, autoimmune disease, bacterial infection, viral infection, pain, central nervous system disease, neurological disease, mood disorders, musculoskeletal disorders, kidney disease, skin disease, osteoporosis, ophthalmic disorders, sensory organ disorders, aging-related diseases.; 005; 006; 018; 044; 046; 051; 052

Case Type Trademark